NS: 25332330
Mobile: 90094424
2:00 – 6:00 pm (weekdays)
Sat. 10:30 AM - 1:30 PM.

News & Articles

14/05/2020

Repurposed drug helps obese mice lose weight, improve metabolic function

Treatment with disulfiram, normally prescribed to treat alcohol use disorder, shows health benefits in animal study. Read More

11/05/2020

Coordinated strategy to accelerate multiple COVID-19 vaccine candidates is key, NIH experts say

More than one effective vaccine approach likely will be required to successfully protect the global community from SARS-CoV-2. Read More

08/05/2020

NIH clinical trial testing antiviral remdesivir plus anti-inflammatory drug baricitinib for COVID-19 begins

The trial is now enrolling hospitalized adults with COVID-19 in the United States. Read More

07/05/2020

NIH-supported research survey to examine impact of COVID-19 on rare diseases community

For the millions of people living with a rare disease, the novel coronavirus disease COVID-19 presents unique challenges. Read More

07/05/2020

Emergency drug overdose visits associated with increased risk for later suicide

NIH-funded study highlights importance of emergency department-based interventions for mitigating suicide risk. Read More

07/05/2020

NIH-funded study links early sleep problems to autism diagnosis among at-risk children

Previous research has shown that young children who have a sibling with ASD are at a higher risk for also being diagnosed with the condition. Read More

05/05/2020

MRI technique could reduce need for radiation in measuring tumor response to chemotherapy

NIH-funded study may have implications for pediatric cancer treatment. Read More

05/05/2020

NIH Statement on World Asthma Day 2020

Asthma is a chronic lung disease that causes periods of wheezing, chest tightness, shortness of breath, and coughing. Read More

04/05/2020

Study to determine incidence of novel coronavirus infection in U.S. children begins

NIH-funded study also will ascertain percentage of infected children who develop COVID-19. Read More

29/04/2020

NIH clinical trial shows Remdesivir accelerates recovery from advanced COVID-19

Preliminary results indicate that patients who received remdesivir had a 31% faster time to recovery than those who received placebo. Read More

slot depo 10k
slot server hongkong
spaceman slot
gatotkaca slot
slot bonus new member 100
NAGAHOKI88